Home NDC 0093-9018-19 NDC 0093-9018-19 - Cyclosporine Modified This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 0093-9018
Requested NDC 0093-9018-19
Package NDCs from labels 0093-9018-19, 0093-9018-65
Manufacturer Teva Pharmaceuticals USA, Inc.
Effective date 2024-04-01
Current FDA listing Not matched in FDA.report NDC product tables
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0093-9018-19 CyclosporineModified 1 in 1 BLISTER PACK CAPSULE, LIQUID FILLED 1 10 0093-9018-65 CyclosporineModified 30 in 1 CARTON CAPSULE, LIQUID FILLED 30 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0093-9018 CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA, INC.] 10 Current NDC, Legacy NDC, 2 package rows 20250227_2de1e8b1-625f-43ce-a1d5-d543be208b11.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CYCLOSPORINE ACTIVE INGREDIENT 83HN0GTJ6D CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 CYCLOSPORINE ACTIVE MOIETY 83HN0GTJ6D CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 .ALPHA.-TOCOPHEROL, DL- INACTIVE INGREDIENT 7QWA1RIO01 CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 ALCOHOL INACTIVE INGREDIENT 3K9958V90M CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 BROWN IRON OXIDE INACTIVE INGREDIENT 1N032N7MFO CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 GLYCINE INACTIVE INGREDIENT TE7660XO1C CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 POLYGLYCERYL-10 OLEATE INACTIVE INGREDIENT 55C81W76DH CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 POLYGLYCERYL-3 OLEATE INACTIVE INGREDIENT XRQ165498B CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 POLYOXYL 40 HYDROGENATED CASTOR OIL INACTIVE INGREDIENT 7YC686GQ8F CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 SORBITOL INACTIVE INGREDIENT 506T60A25R CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CYCLOSPORINE MODIFIED (CYCLOSPORINE) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 5 of 272 · 5,427 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.